Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
|Articles|March 27, 2009
Drug Topics Media Information
Advertisement
Drug Topics is the only newsmagazine for pharmacists that reports on all facets of pharmacy. The goal of Drug Topics is to keep today’s busy pharmacists informed about and prepared for the clinical, professional, business, legal, and governmental developments that impact their pharmacy and to provide this content in a concise, easy-to-read format.
Drug Topics has consistently published news for community pharmacists for 153 years as well as clinical information that is of great value to health-system pharmacists in the hospital setting.
- Ranked #2 in both Readership and Exposures (Mars Fall ’08)
For Advertising, Custom Programs, and Web:Alison O'Connor
National Account Manager
212-951-6731
For Display, Classifieds, Product & Service Showcase, and Web:Carla Kastanis
Marketing Advisor
440-891-2711
For Recruitment, Enews and Digital Editions:Joanna Shippoli
Marketing Advisor
440-891-2615
For Lists:Tamara Phillips
Marketing Advisor
440-891-2773
For contracts, insertions orders, other instructions,publication-set copy, reproduction materials, electronic file disks andproofs:Jane Dzuck
Sr. Production Manager
218-740-6313
For detailed digital ad specifications and to submit your materials,
Print Solutions:
Multimedia Solutions:
Advertisement
Related to this article
Madeline Sutton, MD, MPH, FACOG, joins to discuss risks of HPV infection among women and how pharmacists can improve outcomes in this area.
In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.
A study found that age and physical comorbidities—not psychiatric diagnosis—were associated with nonpsychotropic polypharmacy.
As pharmacists vocalize their willingness to fill in health care gaps, the integration of public health and emerging pharmacy professionals could be profound.
The expert explains 2025-1016 flu, COVID-19, and RSV vaccine updates from AAP, ACOG, AAFP, and IDSA, and what changing schedules mean for pharmacists.
A persistence of pneumococcal meningitis among adults transformed the disease into a public health concern pharmacists fight on a population-wide scale.
An analysis found all-cause pneumonia Black, lower-income, and medically at-risk children still face substantially higher rates of hospitalization.
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
Expert Discusses Flu and COVID-19 Vaccine Guidance
5